Undifferentiated Spondyloarthropathy (USpA) is a form of inflammatory arthritis that belongs to the spondyloarthritis family but does not meet the full diagnostic criteria for specific conditions such as ankylosing spondylitis, psoriatic arthritis, or reactive arthritis.
People with USpA experience symptoms like chronic joint pain, inflammation, and stiffness – especially in the spine, lower back, or peripheral joints – but without the defining features of other spondyloarthropathies. In some individuals, USpA may remain mild and stable, while in others it can evolve over time into a more clearly defined condition.
Early recognition and management are important. With timely treatment, inflammation can be controlled, symptoms reduced, and long-term joint damage prevented. Many patients can maintain a good quality of life with proper care and monitoring.
Living with USpA can also affect emotional well-being. Chronic pain and uncertainty around diagnosis may cause stress or anxiety. Ongoing medical support and patient education play a key role in effective disease management.
USpA does not follow a single pattern and may present differently in each individual. Common patterns include:
Primarily affects joints outside the spine, such as knees, ankles, wrists, or shoulders. Joint swelling and pain may be asymmetric.
Involves inflammation of the lower back, spine, or sacroiliac joints. Symptoms include chronic back pain and morning stiffness that improves with movement.
Some individuals experience both axial (spine-related) and peripheral joint symptoms, along with tendon or ligament inflammation.
The exact cause of USpA is not fully understood, but it is believed to result from a combination of immune system activity, genetics, and environmental triggers.
Symptoms may develop gradually or appear suddenly and can vary in severity over time.
Diagnosis is based on a combination of symptoms, clinical evaluation, and test results:
Because symptoms may overlap with other conditions, regular follow-up is important to monitor disease progression.